1Goldberg RJ,Yarzebski J,Lessard D,et al. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction :a community-wide perspective. Am Heart J, 2002,143:519-527. 被引量：1
2Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol,2007 ,100 :753-757. 被引量：1
3Wong CK ,White HD,Wilcox RG, et al. Significance of atrial fibrillation during acute myocardial infarction ,and its current management :insights from the GUSTO-3 trial. Card Electrophysiol Rev,2003 ,7 :201-207. 被引量：1
4Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol,2003 ,92 :1150-1154. 被引量：1
5Pedersen OD,Abildstrom SZ, Ottesen MM, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J, 2006, 27:290-295. 被引量：1
7Sakata K,Kurihara H,Iwamori K,et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol, 1997,80 : 1522-1527. 被引量：1
8Cieek D,Camsari A,Pekdemir H,et al. Predictive value of P-wave signal-averaged electrocardiogram for atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electroeardiol,2003 ,8 :233-237. 被引量：1
9Yilmaz R, Kasap H, Baykan M, et al. Assessment of left ventricular function by Doppler tissue imaging in patients with atrial fibrillation following acute myocardial infarction. Int J Cardiol, 2005,102:79-85. 被引量：1
10Baykan M, Celik S, Erdol C, et al. Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction. Ann Noninvasive Electrocardiol,2003 ,8 :101-106. 被引量：1
同被引文献9
1Fuster V, Ryden L E, Cannom D S, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J]. Circulation, 2006,114 (7) : e257- e354. 被引量：1
2Camm A J, Kirchhof P, Lip G Y, et al. Guidelines for the manage- ment of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Eur Heart 1,2010,31(19):2369--2429. 被引量：1
3Connolly S J, Ezekowitz M D, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N gngl J Med, 2009, 361(12) :1139-- 1151. 被引量：1
